SingHealth Duke-NUS Academic Medical Centre and Cordlife partner to advance stem cell technology to first-in-man clinical trial in Singapore asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Upon collection after the delivery of a baby, cord blood is processed to extract stem cells and to prepare it for long-term cryopreservation view more
Credit: Cordlife Group Limited
SINGAPORE, 11 May 2021 - Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore s first private cord blood bank, Cordlife Group Limited (Cordlife), to test a novel technology that expands the number of blood-forming stem cells from stored umbilical cord blood (UCB) in a first-in-man study in Singapore. This is the first time a home-grown UCB cell therapy is being tested on humans. The technology has the potential to increase treatment options for patients suffering from blood cancers or blood-related conditions.
Biotech startups Tzar Labs, Epigeneres Biotechnology claim breakthrough in cancer detection using novel blood test yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early
Tzar Labs announces breakthrough in early-stage cancer with simple blood test
Tzar Labs announces breakthrough in early-stage cancer with simple blood test
Last Updated: Fri, May 7th, 2021, 19:20:20hrs
New Delhi, May 7 (IANS) Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early-detection and prognosis/diagnosis of cancer. This is possible with a novel blood test - a world-first - that can help determine whether cancer is absent, imminent, or present, and also detect different stages of the disease, a company statement said.
This will pave the way for widespread early detection and treatment of cancer, thereby potentially saving millions of lives. This innovation will redefine cancer diagnostics through precise and accurate detection before any symptoms or tumours develop, it said.